CYSTAGON Drug Patent Profile
✉ Email this page to a colleague
When do Cystagon patents expire, and what generic alternatives are available?
Cystagon is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in CYSTAGON is cysteamine bitartrate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cysteamine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYSTAGON?
- What are the global sales for CYSTAGON?
- What is Average Wholesale Price for CYSTAGON?
Summary for CYSTAGON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Clinical Trials: | 11 |
| Drug Prices: | Drug price information for CYSTAGON |
| What excipients (inactive ingredients) are in CYSTAGON? | CYSTAGON excipients list |
| DailyMed Link: | CYSTAGON at DailyMed |
Recent Clinical Trials for CYSTAGON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Nacuity Pharmaceuticals, Inc. | Phase 1/Phase 2 |
| NHS Grampian | Phase 1/Phase 2 |
| University of Aberdeen | Phase 1/Phase 2 |
Pharmacology for CYSTAGON
| Drug Class | Cystine Depleting Agent |
| Mechanism of Action | Cystine Disulfide Reduction |
US Patents and Regulatory Information for CYSTAGON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | CYSTAGON | cysteamine bitartrate | CAPSULE;ORAL | 020392-001 | Aug 15, 1994 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | CYSTAGON | cysteamine bitartrate | CAPSULE;ORAL | 020392-002 | Aug 15, 1994 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
